MetaADEDB 2.0 @ LMMD
Vigabatrin
(PJDFLNIOAUIZSL-UHFFFAOYSA-N)
Structure
SMILES
NC(C=C)CCC(=O)O
Type(s)
Approved
ATC code(s)
N03AG04
Molecular Formula:
C6H11NO2
Molecular Weight:
129.157
Log P:
1.0648
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
63.32
CAS Number(s):
60643-86-9; 68506-86-5
Synonym(s)
1.
Vigabatrin
2.
gamma-Vinyl-gamma-Aminobutyric Acid
3.
Sabril
4.
Sabrilex
5.
gamma-Vinyl-GABA
6.
gamma Vinyl GABA
7.
gamma Vinyl gamma Aminobutyric Acid
External Link(s)
MeSHD020888
PubChem Compound25202592
5665
BindingDB50118886
ChEBI63638
CHEMBLCHEMBL89598
DrugBankDB01080
DrugCentral2819
IUPHAR/BPS Guide to PHARMACOLOGY4821
KEGGcpd:C07500
dr:D00535
Therapeutic Target DatabaseD0R3QY
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug dose omissionFAERS: 590US FAERS
2Drug ineffectiveFAERS: 397OFFSIDES
US FAERS
3Drug withdrawal convulsionsFAERS: 175US FAERS
4SomnolenceFAERS: 150SIDER
US FAERS
5PneumoniaFAERS: 142SIDER
US FAERS
6VomitingFAERS: 111SIDER
US FAERS
7Visual ImpairmentFAERS: 87
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8MalaiseFAERS: 80
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
9Incorrect dose administeredFAERS: 64US FAERS
10FatigueFAERS: 61
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
11Product preparation errorFAERS: 45US FAERS
12Wrong technique in product usage processFAERS: 43US FAERS
13Infantile spitting upFAERS: 40OFFSIDES
US FAERS
14InfluenzaFAERS: 37SIDER
US FAERS
15NasopharyngitisFAERS: 37SIDER
US FAERS
16ConstipationFAERS: 32SIDER
US FAERS
17Product dose omissionFAERS: 32US FAERS
18Retinogram abnormalFAERS: 32
Canada Vigilance: 11
Canada Vigilance
US FAERS
19Wrong technique in drug usage processFAERS: 31US FAERS
20LethargyFAERS: 29OFFSIDES
SIDER
US FAERS
21Respiratory distressFAERS: 29US FAERS
22Adverse eventFAERS: 28US FAERS
23CryingFAERS: 28OFFSIDES
US FAERS
24DizzinessFAERS: 26
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
25TremorFAERS: 26SIDER
US FAERS
26BlindnessFAERS: 25US FAERS
27AgitationFAERS: 23
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
28Product substitution issueFAERS: 23US FAERS
29Optic AtrophyFAERS: 20
Canada Vigilance: 2

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
30Status EpilepticusFAERS: 19OFFSIDES
SIDER
US FAERS
31HypersomniaFAERS: 18US FAERS
32InfectionFAERS: 17SIDER
US FAERS
33Respiratory FailureFAERS: 17OFFSIDES
SIDER
US FAERS
34Urinary tract infectionFAERS: 17SIDER
US FAERS
35AngerFAERS: 15US FAERS
36Inappropriate schedule of drug administrationFAERS: 14US FAERS
37Mood swingsFAERS: 14SIDER
US FAERS
38SepsisFAERS: 14US FAERS
39StrabismusFAERS: 14SIDER
US FAERS
40BronchitisFAERS: 13SIDER
US FAERS
41Ophthalmological examination abnormalFAERS: 13US FAERS
42Weight decreasedFAERS: 13US FAERS
43DehydrationFAERS: 12US FAERS
44EpistaxisFAERS: 12US FAERS
45ScreamingFAERS: 12US FAERS
46EpilepsyFAERS: 11

View details

CTD
US FAERS
47Feeling abnormalFAERS: 11SIDER
US FAERS
48Retinal toxicityFAERS: 11
Canada Vigilance: 28
Canada Vigilance
OFFSIDES
US FAERS
49HeadacheFAERS: 1014515344CTD
SIDER
US FAERS
50Unevaluable eventFAERS: 10US FAERS
51AmnesiaFAERS: 9SIDER
US FAERS
52AnxietyFAERS: 9SIDER
US FAERS
53ArthralgiaFAERS: 9SIDER
US FAERS
54BronchiolitisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Cardiac ArrestFAERS: 9US FAERS
56Memory impairmentFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
57NystagmusFAERS: 9SIDER
US FAERS
58Poor quality sleepFAERS: 9US FAERS
59Prescribed overdoseFAERS: 9US FAERS
60PruritusFAERS: 9SIDER
US FAERS
61Toxicity to various agentsFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
62BradycardiaFAERS: 8OFFSIDES
US FAERS
63Change in seizure presentationFAERS: 8US FAERS
64DroolingFAERS: 8US FAERS
65DysgeusiaFAERS: 8US FAERS
66NauseaFAERS: 8SIDER
US FAERS
67Otitis MediaFAERS: 8SIDER
US FAERS
68PainFAERS: 8SIDER
US FAERS
69Respiratory arrestFAERS: 8US FAERS
70Rhinovirus infectionFAERS: 8US FAERS
71Abdominal discomfortFAERS: 7SIDER
US FAERS
72ConjunctivitisFAERS: 7SIDER
US FAERS
73EczemaFAERS: 7US FAERS
74Electroencephalogram abnormalFAERS: 7SIDER
US FAERS
75Intentional product use issueFAERS: 7US FAERS
76Mental status changesFAERS: 7US FAERS
77PhotophobiaFAERS: 7US FAERS
78AlopeciaFAERS: 6US FAERS
79AsthmaFAERS: 6US FAERS
80BlepharospasmFAERS: 6OFFSIDES
US FAERS
81CyanosisFAERS: 6US FAERS
82Drug administration errorFAERS: 6US FAERS
83DystoniaFAERS: 6US FAERS
84Excessive eye blinkingFAERS: 6US FAERS
85HypersensitivityFAERS: 6SIDER
US FAERS
86Myoclonic EpilepsyFAERS: 6SIDER
US FAERS
87NephrolithiasisFAERS: 6US FAERS
88PancreatitisFAERS: 6US FAERS
89Respiratory tract infection viralFAERS: 6US FAERS
90StaringFAERS: 6US FAERS
91Therapy cessationFAERS: 6US FAERS
92Accidental overdoseFAERS: 5OFFSIDES
US FAERS
93Acute respiratory failureFAERS: 5US FAERS
94Chest PainFAERS: 5SIDER
US FAERS
95ChokingFAERS: 5US FAERS
96ChoreaFAERS: 5US FAERS
97CystitisFAERS: 5US FAERS
98Drug dose titration not performedFAERS: 5US FAERS
99Eye painFAERS: 5SIDER
US FAERS
100Head BangingFAERS: 5US FAERS
101HypophagiaFAERS: 5US FAERS
102Inappropriate schedule of product administrationFAERS: 5US FAERS
103Incorrect product storageFAERS: 5US FAERS
104Poor feeding infantFAERS: 5US FAERS
105RetchingFAERS: 5US FAERS
106TonsillectomyFAERS: 5US FAERS
107UnderweightFAERS: 5OFFSIDES
US FAERS
108Viral upper respiratory tract infectionFAERS: 5US FAERS
109Accidental exposure to productFAERS: 4US FAERS
110Cerebrovascular accidentFAERS: 4US FAERS
111Clostridium difficile infectionFAERS: 4US FAERS
112Depressed moodFAERS: 4SIDER
US FAERS
113Gait inabilityFAERS: 4US FAERS
114GastrostomyFAERS: 4US FAERS
115General physical health deteriorationFAERS: 4US FAERS
116HypotensionFAERS: 4US FAERS
117HypoxiaFAERS: 4US FAERS
118Inappropriate affectFAERS: 4US FAERS
119MalabsorptionFAERS: 4US FAERS
120Middle insomniaFAERS: 4US FAERS
121MyoclonusFAERS: 411143506CTD
SIDER
US FAERS
122OverdoseFAERS: 4US FAERS
123Post procedural complicationFAERS: 4US FAERS
124Product use issueFAERS: 4US FAERS
125Protein-losing gastroenteropathyFAERS: 4US FAERS
126QuadranopiaFAERS: 4US FAERS
127RestlessnessFAERS: 4US FAERS
128Sleep TalkingFAERS: 4US FAERS
129TracheitisFAERS: 4US FAERS
130Unresponsive to stimuliFAERS: 4US FAERS
131UrticariaFAERS: 4SIDER
US FAERS
132nervous system disorderFAERS: 4SIDER
US FAERS
133Accidental exposureFAERS: 3US FAERS
134AmblyopiaFAERS: 3US FAERS
135AstheniaFAERS: 3SIDER
US FAERS
136CataractFAERS: 3US FAERS
137ChillsFAERS: 3US FAERS
138Croup infectiousFAERS: 3SIDER
US FAERS
139DisorientationFAERS: 3SIDER
US FAERS
140Drug dispensing errorFAERS: 3US FAERS
141Drug withdrawal syndromeFAERS: 3US FAERS
142Emotional disorderFAERS: 3US FAERS
143Eye InfectionFAERS: 3US FAERS
144Eye irritationFAERS: 3US FAERS
145Failure to ThriveFAERS: 3US FAERS
146GlaucomaFAERS: 3US FAERS
147Head titubationFAERS: 3US FAERS
148Muscle tightnessFAERS: 3US FAERS
149Musculoskeletal stiffnessFAERS: 3US FAERS
150Nonspecific reactionFAERS: 3US FAERS
151OpisthotonusFAERS: 3US FAERS
152Oral dischargeFAERS: 3US FAERS
153Peripheral swellingFAERS: 3US FAERS
154Personality ChangeFAERS: 3US FAERS
155Product taste abnormalFAERS: 3US FAERS
156Psychogenic seizureFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
157RegurgitationFAERS: 3US FAERS
158Respiratory DepressionFAERS: 3US FAERS
159Respiratory tract congestionFAERS: 3SIDER
US FAERS
160Retinal DegenerationFAERS: 3
Canada Vigilance: 2
15329067CTD
SIDER
Canada Vigilance
US FAERS
161Shunt infectionFAERS: 3US FAERS
162treatment failureFAERS: 3US FAERS
163Abdominal PainFAERS: 2SIDER
US FAERS
164Ammonia increasedFAERS: 2US FAERS
165AphagiaFAERS: 2US FAERS
166AsthenopiaFAERS: 2SIDER
US FAERS
167AstigmatismFAERS: 2US FAERS
168AstrocytomaFAERS: 2US FAERS
169Brain scan abnormalFAERS: 2US FAERS
170Brain stem syndromeFAERS: 2US FAERS
171BruxismFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Central nervous system lesionFAERS: 2US FAERS
173Cerebral InfarctionFAERS: 2US FAERS
174Chronic respiratory failureFAERS: 2US FAERS
175Cold sweatFAERS: 2OFFSIDES
US FAERS
176Complex partial seizuresFAERS: 2US FAERS
177Congenital neurological disorderFAERS: 2US FAERS
178Corpus callosotomyFAERS: 2US FAERS
179Decreased eye contactFAERS: 2US FAERS
180Detachment of retinal pigment epitheliumFAERS: 2US FAERS
181Diabetes InsipidusFAERS: 2US FAERS
182DiscomfortFAERS: 2SIDER
US FAERS
183Disease complicationFAERS: 2US FAERS
184Drug level below therapeuticFAERS: 2US FAERS
185Drug titration errorFAERS: 2US FAERS
186Drug toxicityFAERS: 2US FAERS
187Dry skinFAERS: 2US FAERS
188DysphemiaFAERS: 2OFFSIDES
US FAERS
189Epileptic encephalopathyFAERS: 2US FAERS
190Exaggerated startle responseFAERS: 2US FAERS
191Expired product administeredFAERS: 2US FAERS
192Extra dose administeredFAERS: 2US FAERS
193Feeding disorder of infancy OR early childhoodFAERS: 2US FAERS
194Feeling jitteryFAERS: 2US FAERS
195Flat affectFAERS: 2SIDER
US FAERS
196FlatulenceFAERS: 2US FAERS
197FlushingFAERS: 2US FAERS
198GastroenteritisFAERS: 2OFFSIDES
US FAERS
199Gastrointestinal viral infectionFAERS: 2US FAERS
200Gingival HypertrophyFAERS: 2OFFSIDES
US FAERS
201HemiparesisFAERS: 2US FAERS
202HepatomegalyFAERS: 2US FAERS
203Hypothalamo-pituitary disorderFAERS: 2US FAERS
204Incorrect drug dosage form administeredFAERS: 2US FAERS
205Incorrect route of drug administrationFAERS: 2US FAERS
206Increased upper airway secretionFAERS: 2US FAERS
207Insurance issueFAERS: 2US FAERS
208Intentional self-injuryFAERS: 2US FAERS
209Joint injuryFAERS: 2OFFSIDES
US FAERS
210LacerationFAERS: 2US FAERS
211LaryngomalaciaFAERS: 2OFFSIDES
US FAERS
212LissencephalyFAERS: 2OFFSIDES
US FAERS
213Medication ErrorFAERS: 2US FAERS
214MetamorphopsiaFAERS: 2US FAERS
215Muscle SpasticityFAERS: 2SIDER
US FAERS
216Myocardial InfarctionFAERS: 2US FAERS
217NervousnessFAERS: 2SIDER
US FAERS
218Optic NeuropathyFAERS: 2OFFSIDES
US FAERS
219Oropharyngeal painFAERS: 2US FAERS
220Otitis ExternaFAERS: 2US FAERS
221PallorFAERS: 2OFFSIDES
SIDER
US FAERS
222Peripheral embolismFAERS: 2US FAERS
223PneumothoraxFAERS: 2US FAERS
224Product preparation issueFAERS: 2US FAERS
225Product quality issueFAERS: 2US FAERS
226Pulmonary EmbolismFAERS: 2SIDER
US FAERS
227Respiratory syncytial virus bronchiolitisFAERS: 2OFFSIDES
US FAERS
228Retinal pigmentationFAERS: 2US FAERS
229Secretion dischargeFAERS: 2US FAERS
230Shunt malfunctionFAERS: 2US FAERS
231SinusitisFAERS: 2SIDER
US FAERS
232Slow response to stimuliFAERS: 2US FAERS
233SluggishnessFAERS: 2US FAERS
234Stoma site reactionFAERS: 2US FAERS
235StressFAERS: 2US FAERS
236Symptom recurrenceFAERS: 2US FAERS
237ToothacheFAERS: 2SIDER
US FAERS
238Tracheostomy infectionFAERS: 2US FAERS
239Upper respiratory tract irritationFAERS: 2US FAERS
240Urine ketone bodyFAERS: 2US FAERS
241VertigoFAERS: 2SIDER
US FAERS
242Visual acuity tests abnormalFAERS: 2US FAERS
243WheezingFAERS: 2US FAERS
244AbasiaFAERS: 1US FAERS
245Abdominal massFAERS: 1US FAERS
246AbscessFAERS: 1US FAERS
247Acute myocardial infarctionFAERS: 1US FAERS
248AdenoidectomyFAERS: 1US FAERS
249AgnosiaFAERS: 1US FAERS
250AkathisiaFAERS: 1US FAERS
251AnoxiaFAERS: 1US FAERS
252AphasiaFAERS: 1US FAERS
253Apparent life threatening eventFAERS: 1US FAERS
254Application site erythemaFAERS: 1US FAERS
255ArthropathyFAERS: 1OFFSIDES
SIDER
US FAERS
256AutophobiaFAERS: 1US FAERS
257AversionFAERS: 1US FAERS
258Back disorderFAERS: 1US FAERS
259Blood glucose decreasedFAERS: 1OFFSIDES
US FAERS
260Blood glucose fluctuationFAERS: 1US FAERS
261Blood potassium decreasedFAERS: 1US FAERS
262Blood pressure fluctuationFAERS: 1US FAERS
263Blood sodium decreasedFAERS: 1US FAERS
264Blood urine presentFAERS: 1US FAERS
265Bone density abnormalFAERS: 1US FAERS
266Bowel movement irregularityFAERS: 1US FAERS
267BradykinesiaFAERS: 1US FAERS
268Brain HypoxiaFAERS: 1US FAERS
269Canavan DiseaseFAERS: 1US FAERS
270CandidiasisFAERS: 1US FAERS
271Cardiac ablationFAERS: 1US FAERS
272Cataract operationFAERS: 1US FAERS
273Catheter site infectionFAERS: 1US FAERS
274Catheter site inflammationFAERS: 1US FAERS
275Catheter site swellingFAERS: 1US FAERS
276CellulitisFAERS: 1US FAERS
277Cerebral atrophyFAERS: 1OFFSIDES
US FAERS
278Cerebral disorderFAERS: 1US FAERS
279Chemical injuryFAERS: 1US FAERS
280Cortical visual impairmentFAERS: 1US FAERS
281Cranial operationFAERS: 1US FAERS
282CraniotomyFAERS: 1US FAERS
283CycloplegiaFAERS: 1US FAERS
284Dacryostenosis acquiredFAERS: 1US FAERS
285DeliriumFAERS: 1SIDER
US FAERS
286Dental cariesFAERS: 1US FAERS
287Deposit eyeFAERS: 1US FAERS
288Depressed Level of ConsciousnessFAERS: 1SIDER
US FAERS
289Device occlusionFAERS: 1OFFSIDES
US FAERS
290Device related infectionFAERS: 1US FAERS
291Device stimulation issueFAERS: 1US FAERS
292Device therapyFAERS: 1US FAERS
293Disease ProgressionFAERS: 1US FAERS
294Disease recurrenceFAERS: 1US FAERS
295Dropped head syndromeFAERS: 1US FAERS
296Drug effect incompleteFAERS: 1US FAERS
297Drug ineffective for unapproved indicationFAERS: 1US FAERS
298Drug prescribing errorFAERS: 1OFFSIDES
US FAERS
299DyspepsiaFAERS: 1SIDER
US FAERS
300DysphoniaFAERS: 1US FAERS
301DysuriaFAERS: 1US FAERS
302Ear discomfortFAERS: 1US FAERS
303ElectroencephalogramFAERS: 1US FAERS
304Elevated moodFAERS: 1US FAERS
305Enterobacter test positiveFAERS: 1US FAERS
306EnuresisFAERS: 1US FAERS
307Epilepsy surgeryFAERS: 1US FAERS
308ErythemaFAERS: 1US FAERS
309Escherichia infectionFAERS: 1US FAERS
310Escherichia urinary tract infectionFAERS: 1US FAERS
311Exposure via inhalationFAERS: 1US FAERS
312Expulsion of medicationFAERS: 1US FAERS
313Eye allergyFAERS: 1US FAERS
314Eyelid irritationFAERS: 1OFFSIDES
US FAERS
315Facial ParesisFAERS: 1US FAERS
316Feeding disorder neonatalFAERS: 1OFFSIDES
US FAERS
317Feeding intoleranceFAERS: 1US FAERS
318Focal dyscognitive seizuresFAERS: 1US FAERS
319FormicationFAERS: 1US FAERS
320Fundoscopy abnormalFAERS: 1US FAERS
321Fungal test positiveFAERS: 1US FAERS
322Gastric DilatationFAERS: 1US FAERS
323Gastric ulcerFAERS: 1US FAERS
324Gastrointestinal hypomotilityFAERS: 1US FAERS
325Gastrostomy tube site complicationFAERS: 1US FAERS
326Gaze palsyFAERS: 1US FAERS
327General symptomFAERS: 1US FAERS
328Genital infection fungalFAERS: 1US FAERS
329Histiocytosis haematophagicFAERS: 1US FAERS
330HordeolumFAERS: 1US FAERS
331Hormone level abnormalFAERS: 1US FAERS
332HungerFAERS: 1US FAERS
333HydrocephalusFAERS: 1US FAERS
334HyperkinesiaFAERS: 1SIDER
US FAERS
335HyperphagiaFAERS: 1US FAERS
336HypervigilanceFAERS: 1US FAERS
337HypokinesiaFAERS: 1US FAERS
338HypopituitarismFAERS: 1US FAERS
339IleusFAERS: 1US FAERS
340Illogical thinkingFAERS: 1US FAERS
341Incision site painFAERS: 1US FAERS
342Incorrect drug administration durationFAERS: 1US FAERS
343Incorrect drug administration rateFAERS: 1US FAERS
344Increased bronchial secretionFAERS: 1US FAERS
345Infantile asthmaFAERS: 1US FAERS
346Infantile vomitingFAERS: 1US FAERS
347Initial insomniaFAERS: 1US FAERS
348Intestinal ObstructionFAERS: 1US FAERS
349Joint swellingFAERS: 1US FAERS
350Lack of spontaneous speechFAERS: 1US FAERS
351Lennox-Gastaut syndromeFAERS: 1US FAERS
352Limb discomfortFAERS: 1US FAERS
353Limb injuryFAERS: 1US FAERS
354Macular fibrosisFAERS: 1US FAERS
355Malignant neoplasm progressionFAERS: 1US FAERS
356Manufacturing product shipping issueFAERS: 1US FAERS
357Medical device changeFAERS: 1US FAERS
358Medical device site abscessFAERS: 1US FAERS
359Metapneumovirus infectionFAERS: 1US FAERS
360MetastasisFAERS: 1US FAERS
361MisophoniaFAERS: 1US FAERS
362Mitochondrial cytopathyFAERS: 1US FAERS
363Multiple allergiesFAERS: 1OFFSIDES
US FAERS
364Muscle RigidityFAERS: 1US FAERS
365Muscle strainFAERS: 1SIDER
US FAERS
366MyalgiaFAERS: 1SIDER
US FAERS
367Myasthenia GravisFAERS: 1US FAERS
368MydriasisFAERS: 1US FAERS
369Neck PainFAERS: 1US FAERS
370Neurostimulator implantationFAERS: 1US FAERS
371NeutropeniaFAERS: 1US FAERS
372No adverse eventFAERS: 1US FAERS
373Ocular discomfortFAERS: 1US FAERS
374Optic Nerve HypoplasiaFAERS: 1US FAERS
375Optic NeuritisFAERS: 18164764CTD
SIDER
US FAERS
376Oral administration complicationFAERS: 1US FAERS
377OsteomyelitisFAERS: 1US FAERS
378Oxygen supplementationFAERS: 1US FAERS
379Pancreatic CystFAERS: 1US FAERS
380Pancreatic PseudocystFAERS: 1US FAERS
381ParanoiaFAERS: 1SIDER
US FAERS
382PetechiaeFAERS: 1US FAERS
383PharyngitisFAERS: 1US FAERS
384PneumonitisFAERS: 1US FAERS
385Poor peripheral circulationFAERS: 1US FAERS
386Postictal psychosisFAERS: 1US FAERS
387Precocious PubertyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
388PregnancyFAERS: 1US FAERS
389PriapismFAERS: 1US FAERS
390Procedural complicationFAERS: 1OFFSIDES
US FAERS
391Procedural vomitingFAERS: 1US FAERS
392Product availability issueFAERS: 1US FAERS
393Product container issueFAERS: 1US FAERS
394Product difficult to swallowFAERS: 1US FAERS
395Product formulation issueFAERS: 1US FAERS
396Product packaging issueFAERS: 1US FAERS
397Product prescribing errorFAERS: 1US FAERS
398Product residue presentFAERS: 1US FAERS
399Product use complaintFAERS: 1US FAERS
400Product use in unapproved indicationFAERS: 1US FAERS
401Productive CoughFAERS: 1US FAERS
402Pulmonary congestionFAERS: 1SIDER
US FAERS
403PyelonephritisFAERS: 1US FAERS
404Refusal of treatment by relativeFAERS: 1US FAERS
405Renal embolismFAERS: 1US FAERS
406Retinal DetachmentFAERS: 1US FAERS
407Retinal depigmentationFAERS: 1US FAERS
408Retinal pallorFAERS: 1US FAERS
409Seizure like phenomenaFAERS: 1US FAERS
410Septic ShockFAERS: 1US FAERS
411Skin lacerationFAERS: 1US FAERS
412Spinal cord abscessFAERS: 1US FAERS
413Stem cell transplantFAERS: 1US FAERS
414StomatitisFAERS: 1US FAERS
415StridorFAERS: 1OFFSIDES
SIDER
US FAERS
416TachycardiaFAERS: 1US FAERS
417Tardive DyskinesiaFAERS: 1US FAERS
418Temperature intoleranceFAERS: 1US FAERS
419Terminal stateFAERS: 1US FAERS
420Therapeutic procedureFAERS: 1US FAERS
421Therapeutic product effect incompleteFAERS: 1US FAERS
422Therapeutic response changedFAERS: 1US FAERS
423Therapeutic response unexpectedFAERS: 1US FAERS
424Therapy non-responderFAERS: 1US FAERS
425Thermal burnFAERS: 1US FAERS
426Throat irritationFAERS: 1SIDER
US FAERS
427ThrombocytopeniaFAERS: 1US FAERS
428TinnitusFAERS: 1SIDER
US FAERS
429Tongue movement disturbanceFAERS: 1US FAERS
430TracheomalaciaFAERS: 1US FAERS
431TrichorrhexisFAERS: 1US FAERS
432TrismusFAERS: 1US FAERS
433UlcerFAERS: 1US FAERS
434Ultrasound scan abnormalFAERS: 1US FAERS
435Upper airway obstructionFAERS: 1US FAERS
436Urinary RetentionFAERS: 1US FAERS
437Urinary sediment presentFAERS: 1US FAERS
438Urinary tract infection enterococcalFAERS: 1US FAERS
439Urine output increasedFAERS: 1US FAERS
440Vascular device infectionFAERS: 1US FAERS
441Vascular stenosisFAERS: 1US FAERS
442Visual AgnosiaFAERS: 1US FAERS
443Withdrawal of life supportFAERS: 1US FAERS
444Wound InfectionFAERS: 1US FAERS
445skin abrasionFAERS: 1US FAERS
446Abdominal wall cystOFFSIDES
447Abnormal visionSIDER
448AcneSIDER
449Acute psychosisSIDER
450Aggressive reactionSIDER
451Alcohol-Induced Disorders11267634CTD
452Alexander Disease10802771CTD
453AlveolitisOFFSIDES
454Amino acid level increasedOFFSIDES
455Amphetamine-Related Disorders15543630
16966620
19016239
CTD
456AngioedemaSIDER
457AnhidrosisOFFSIDES
458Antidepressant drug clearance increasedOFFSIDES
459ApathySIDER
460ArthrogramOFFSIDES
461Aspiration PneumoniaOFFSIDES
462AtaxiaSIDER
463Back PainSIDER
464Basal Ganglia Diseases18783433CTD
465Bipolar Disorder7906364
8088239
CTD
466Blood and lymphatic system disordersSIDER
467Blood pH increasedOFFSIDES
468Brain Diseases8101289
10802771
11143506
CTD
469Brain Injuries11673025
25554247
CTD
470Cerebral Palsy8980841CTD
471Cerebral dysgenesisOFFSIDES
472Cerebral ventricle dilatationOFFSIDES
473Choking sensationOFFSIDES
474CholecystitisOFFSIDES
475CholestasisSIDER
476ClonusOFFSIDES
477Coagulation factor XIII level decreasedOFFSIDES
478Cocaine-Related Disorders

View details

CTD
479Concomitant disease progressionOFFSIDES
480Congenital heart diseaseOFFSIDES
481Congenital hydronephrosisSIDER
482DeafnessSIDER
483Delayed PubertyOFFSIDES
SIDER
484Demyelinating Diseases19773459CTD
485Dentofacial anomalySIDER
486Depressive disorder10534259
17987732
CTD
487DermatitisSIDER
488Developmental Coordination DisorderSIDER
489DiplopiaSIDER
490Disorders of Excessive Somnolence10802771
16169023
CTD
491DrowsinessOFFSIDES
SIDER
492Drug resistanceOFFSIDES
493DysarthriaSIDER
494DysgraphiaOFFSIDES
495DysmorphismSIDER
496Enzyme abnormalityOFFSIDES
497Epilepsies, Partial

View details

CTD
498Epilepsy, Complex Partial10880283CTD
499Epilepsy, Temporal Lobe7906364
10802764
11284756
CTD
500Erectile dysfunctionSIDER
501Erythema MultiformeSIDER
502Fetal Growth Retardation9181670CTD
503Gait Disorders, Neurologic17438226CTD
504Gastrointestinal PainSIDER
505Gestational DiabetesOFFSIDES
506HamartomaCanada Vigilance: 1Canada Vigilance
SIDER
507Head deformityOFFSIDES
508Hearing Loss, Bilateral14557592CTD
509HepatitisCanada Vigilance: 1Canada Vigilance
510HerniaOFFSIDES
511Heroin Dependence14515344CTD
512Hip DysplasiaSIDER
513Hip surgeryOFFSIDES
514HydronephrosisOFFSIDES
515HyperreflexiaSIDER
516HypomaniaSIDER
517HyporeflexiaSIDER
518HypospadiasOFFSIDES
519IlliteracyOFFSIDES
520InfestationSIDER
521Ischemia8164764CTD
522Joint sprainSIDER
523Low set earsOFFSIDES
SIDER
524Malformations of Cortical Development17346254
18166379
CTD
525MalnutritionSIDER
526Mental RetardationSIDER
527Mild Mental RetardationOFFSIDES
528Mood Disorders10880283CTD
529Morphine Dependence14515344CTD
530Muscle relaxant therapySIDER
531Musculoskeletal discomfortSIDER
532Neurobehavioral Manifestations10840396CTD
533OliguriaOFFSIDES
534PROTHROMBIN TIMEOFFSIDES
535Paranoid reactionSIDER
536Pectus excavatumOFFSIDES
537Pharyngolaryngeal PainSIDER
538PhimosisOFFSIDES
539PlagiocephalyOFFSIDES
540Platelet count abnormalOFFSIDES
541Platelet function test abnormalOFFSIDES
542PosturingOFFSIDES
543Premenstrual syndromeCanada Vigilance: 1Canada Vigilance
544PseudoporphyriaOFFSIDES
545Psychoses, Substance-Induced8573955CTD
546Psychotic Disorders8717341
10534259
10880283
CTD
547PurpuraSIDER
548Pyloric StenosisOFFSIDES
549Recurrence17346254CTD
550Retinal Diseases

View details

CTD
551RetinitisSIDER
552RetrocollisOFFSIDES
553RetrognathiaOFFSIDES
554ScotomaOFFSIDES
SIDER
555Seizures

View details

CTD
556Sinus headacheSIDER
557Stevens-Johnson SyndromeSIDER
558Stupor8101289
10802771
CTD
SIDER
559Substance Withdrawal Syndrome17346254CTD
560Suicide attemptSIDER
561TalipesSIDER
562TensionSIDER
563Thalamic Diseases18783433CTD
564ThirstCanada Vigilance: 1Canada Vigilance
SIDER
565Toxic Epidermal NecrolysisSIDER
566TractionOFFSIDES
567Tuberous Sclerosis18479386CTD
568Upset stomachSIDER
569Urinary tract infection pseudomonalOFFSIDES
570Vascular purpuraSIDER
571Vasculitis, Leukocytoclastic, Cutaneous8164764CTD
572Vision Disorders

View details

CTD
573Visual field constrictionSIDER
574Wave slowingSIDER
575jaundiceCanada Vigilance: 1Canada Vigilance
576succinic semialdehyde dehydrogenase deficiency20018576CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.